Published in Thromb Haemost on December 29, 1984
Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial. BMJ (2007) 3.26
Audit of start of anticoagulation treatment in inpatients. J Clin Pathol (1993) 1.49
Anticoagulation in venous thrombosis. J R Soc Med (1996) 0.75
The Perioperative Management of Antithrombotic Therapies Using Enoxaparin. J Korean Med Sci (2017) 0.75
Increased fetal loss in women with heritable thrombophilia. Lancet (1996) 3.34
Human fibrinopeptides. Isolation, characterization and structure. Biochim Biophys Acta (1966) 3.18
Transmission of hepatitis C with pasteurised factor VIII. Lancet (1992) 2.62
Altered striatal dopamine re-uptake site densities in habitually violent and non-violent alcoholics. Nat Med (1995) 2.40
Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med (1985) 2.39
Validation of a composite score for clinical severity of hemophilia. J Thromb Haemost (2008) 2.33
Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet (1987) 2.23
Real-world variability in dabigatran levels in patients with atrial fibrillation. J Thromb Haemost (2015) 2.07
Graduated compression stockings to treat acute leg pain associated with proximal DVT. A randomised controlled trial. Thromb Haemost (2014) 2.02
Induction of crisis forms in the human malaria parasite Plasmodium falciparum by gamma-interferon-activated, monocyte-derived macrophages. J Immunol (1984) 1.95
Redistribution of membrane proteins in isolated mouse intestinal epithelial cells. J Cell Biol (1980) 1.94
Effect of low-dose heparin on incidence of postoperative pulmonary embolism detected by photoscanning. Lancet (1974) 1.91
Macroprolactinomas: serial MR imaging in long-term bromocriptine therapy. AJNR Am J Neuroradiol (1992) 1.90
Retrospective study of the correlation between the DNA repair protein alkyltransferase and survival of brain tumor patients treated with carmustine. Cancer Res (1996) 1.68
Recommendations on biosimilar low-molecular-weight heparins. J Thromb Haemost (2009) 1.68
Determination of acetylcholine receptor antibody in myasthenia gravis: clinical usefulness and pathogenetic implications. J Neurol Neurosurg Psychiatry (1978) 1.68
Clinical and haemostatic parameters related to thromboembolism and low-dose heparin prophylaxis in major surgery. Acta Chir Scand (1975) 1.67
Selexipag for the Treatment of Pulmonary Arterial Hypertension. N Engl J Med (2015) 1.62
Correlation of tumor O6 methylguanine-DNA methyltransferase levels with survival of malignant astrocytoma patients treated with bis-chloroethylnitrosourea: a Southwest Oncology Group study. J Clin Oncol (1998) 1.61
Nanobacteria: an infectious cause for kidney stone formation. Kidney Int (1999) 1.59
Altered properties of the fibrin gel structure in patients with IDDM. Diabetologia (1996) 1.57
Fondaparinux treatment of acute heparin-induced thrombocytopenia confirmed by the serotonin-release assay: a 30-month, 16-patient case series. J Thromb Haemost (2011) 1.54
Decreased fibrin network permeability and impaired fibrinolysis in the acute and convalescent phase of ischemic stroke. Thromb Res (2010) 1.48
Rhoptry secretion of membranous whorls by Plasmodium falciparum merozoites. Am J Trop Med Hyg (1986) 1.47
Peripheral nerve function in pernicious anemia before and after treatment. Acta Haematol (1969) 1.44
Antithrombin-III-Stockholm: a codon 392 (Gly----Asp) mutation with normal heparin binding and impaired serine protease reactivity. Blood (1992) 1.41
Vitamin K antagonists and cancer: rebuttal. J Thromb Haemost (2004) 1.40
An analysis of contact-service in the Migrant Health Service Referral System (MHSRS). Am J Public Health (1971) 1.38
Plasmodium berghei sporozoite invasion is blocked in vitro by sporozoite-immobilizing antibodies. Infect Immun (1986) 1.37
Antithrombin III supplementation for patients undergoing PTCA for unstable angina pectoris. A controlled randomized double-blind pilot study. Eur Heart J (1997) 1.37
Fibrinogen Detroit--a molecular defect in the N-terminal disulphide knot of human fibrinogen? Nature (1968) 1.36
Serological investigation of granulocytic Ehrlichia infection in sheep in Norway. Acta Vet Scand (2001) 1.35
Cerebrospinal fluid ferritin in patients with cerebral infarction or bleeding. Acta Neurol Scand (1980) 1.34
N-terminal disulphide knot of human fibrinogen. Nature (1968) 1.33
Relapse of acute leukemia after marrow transplantation: natural history and results of subsequent therapy. J Clin Oncol (1989) 1.33
Coagulation factors and the increased risk of stroke in nonvalvular atrial fibrillation. Stroke (1990) 1.33
Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized. Br J Haematol (1999) 1.32
Hypercoagulable state and thromboembolism following warfarin withdrawal in post-myocardial-infarction patients. Eur Heart J (1991) 1.28
Human resources for control of tuberculosis and HIV-associated tuberculosis. Int J Tuberc Lung Dis (2005) 1.28
Cerebral computed tomography in methanol intoxication. J Comput Assist Tomogr (1980) 1.27
Detection of Mycoplasma hyopneumoniae in nose swabs from pigs by in vitro amplification of the 16S rRNA gene. J Clin Microbiol (1995) 1.24
Hemostatic effect of tranexamic acid mouthwash in anticoagulant-treated patients undergoing oral surgery. N Engl J Med (1989) 1.23
On the value of menorrhagia as a predictor for coagulation disorders. Am J Hematol (1996) 1.23
Proneness to formation of tight and rigid fibrin gel structures in men with myocardial infarction at a young age. Thromb Haemost (1996) 1.20
Acetylcholine receptor antibody in myasthenia gravis: purification and characterization. Scand J Immunol (1978) 1.19
Dopamine reuptake site densities in patients with social phobia. Am J Psychiatry (1997) 1.18
Neonatal aortic thrombosis. A possible clinical manifestation of congenital antithrombin 3 deficiency. Acta Paediatr Scand (1974) 1.16
Prevention of postsurgical bleeding in oral surgery using tranexamic acid without dose modification of oral anticoagulants. J Oral Maxillofac Surg (1993) 1.15
Acute non-rheumatic myopericarditis: a follow-up study. Scand J Infect Dis (1970) 1.15
Haemostatic, endothelial and lipoprotein parameters and blood pressure levels in women with a history of preeclampsia. Thromb Haemost (1999) 1.13
An orthopantomographic study of hypodontia, supernumeraries and other anomalies in school children between the ages of 8-9 years. An epidemiological study. Swed Dent J (1977) 1.13
Genetic and cultural inheritance of plasma fibrinogen concentration. Lancet (1987) 1.12
Protein C, protein S and C4b-binding protein in severe infection and septic shock. Thromb Haemost (1991) 1.11
Coagulation, fibrinolysis, and kallikrein systems in sepsis: relation to outcome. Crit Care Med (1989) 1.11
Incidence of symptoms and AIDS in 146 Swedish haemophiliacs and blood transfusion recipients infected with human immunodeficiency virus. BMJ (1988) 1.11
Immunoglobulins in myasthenia gravis: effect of human lymph IgG 3 and F (ab')2 fragments on a cholinergic receptor preparation from Torpedo marmorata. Eur J Clin Invest (1977) 1.10
Successful use of recombinant factor VIIa in patient with severe haemophilia A during synovectomy. Lancet (1988) 1.09
Protein-rejecting ability of surface-bound dextran in end-on and side-on configurations: comparison to PEG. J Biomed Mater Res (1995) 1.09
Rhoptry secretion of membranous whorls by Plasmodium berghei sporozoites. J Protozool (1985) 1.06
The effect of thoracic duct lymph drainage in myasthenia gravis. Eur Neurol (1973) 1.05
Adverse effects on the brain in cardiac operations as assessed by biochemical, psychometric, and radiologic methods. J Thorac Cardiovasc Surg (1984) 1.05
Cerebral benzodiazepine receptor binding and distribution in generalized anxiety disorder: a fractal analysis. Mol Psychiatry (1998) 1.05
Reduced weight gain due to subclinical Anaplasma phagocytophilum (formerly Ehrlichia phagocytophila) infection. Exp Appl Acarol (2002) 1.05
Primary structure of human fibrinogen and fibrin. I. Clevage of fibrinogen with cyanogen bromide. Isolation and characterization of NH 2 -terminal fragments of the ("A") chain. J Biol Chem (1972) 1.04
Effect of a simple two-step warfarin dosing algorithm on anticoagulant control as measured by time in therapeutic range: a pilot study. J Thromb Haemost (2009) 1.04
Effects of some immunosuppressive procedures on myasthenia gravis. Ann N Y Acad Sci (1976) 1.04
Our experience in Sweden with prophylaxis on haemophilia. Bibl Haematol (1970) 1.03
Effects of acute beta-adrenergic receptor blockade on age-associated changes in cardiovascular performance during dynamic exercise. Circulation (1994) 1.02
Prophylaxis with factor concentrates in preventing hemophilic arthropathy. Am J Pediatr Hematol Oncol (1991) 1.02
Structure of N-terminal fragments of fibrinogen and specificity of thrombin. Nature (1967) 1.02
Periprocedural antithrombotic and bridging therapy: recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy. J Thromb Haemost (2012) 1.01
The molecular structure of fibrinogen. Ann N Y Acad Sci (1972) 1.01
Diagnosis of contagious caprine pleuropneumonia by detection and identification of Mycoplasma capricolum subsp. capripneumoniae by PCR and restriction enzyme analysis. J Clin Microbiol (1996) 1.01
Vacutainer sampling for blood coagulation assays. Scand J Clin Lab Invest (1978) 1.01
Hypersensitive reactions and antibody formation during L-asparaginase treatment of children and adults with acute leukemia. Cancer (1976) 1.00
The role of the fibrinolytic system in deep vein thrombosis. J Lab Clin Med (1985) 1.00
Why bother with stop-smoking education for lung cancer patients? Oncol Nurs Forum (1984) 1.00
Determination of vitamin K sensitive coagulation factors in plasma: studies on three methods using synthetic chromogenic substrates. Thromb Res (1978) 1.00
Increased nicotinamide adenine dinucleotide content and synthesis in Plasmodium falciparum-infected human erythrocytes. Blood (1990) 0.99
Factor VII deficiency: clinical manifestation of 717 subjects from Europe and Latin America with mutations in the factor 7 gene. Haemophilia (2008) 0.99
Malarial pigment-dependent error in the estimation of hemoglobin content in Plasmodium falciparum-infected red cells: implications for metabolic and biochemical studies of the erythrocytic phases of malaria. Am J Trop Med Hyg (1986) 0.98
Determination of plasma prothrombin with a reaction rate analyzer using a synthetic substrate. Thromb Res (1974) 0.98
Social support and the development of immune function in human immunodeficiency virus infection. Psychosom Med (1995) 0.98
Increased concentrations of lactate dehydrogenase in pregnancy with preeclampsia: a predictor for the birth of small-for-gestational-age infants. Gynecol Obstet Invest (1995) 0.98
Comparison of once-daily subcutaneous Fragmin with continuous intravenous unfractionated heparin in the treatment of deep vein thrombosis. Thromb Haemost (1994) 0.97
The role of recombinant factor VIIa (FVIIa) in fibrin structure in the absence of FVIII/FIX. J Thromb Haemost (2003) 0.97
Osseointegrated implants in children: experience from our first 100 patients. Otolaryngol Head Neck Surg (2001) 0.97
Stage-dependent toxicity of N-acetyl-glucosamine to Plasmodium falciparum. J Protozool (1985) 0.96
Perioperative anticoagulation in patients having implantation of a cardiac pacemaker or defibrillator: a systematic review and practical management guide. J Thromb Haemost (2008) 0.96
Magnetic resonance imaging of the brain in Wilson's disease. Neuroradiology (1993) 0.96
Trimethylsilylation of amino acids. I. Study of glycine and lysine TMS derivatives with gas-liquid chromatography-mass spectrometry. Anal Biochem (1970) 0.95
Thrombocytopenia and bleeding complications in severe cases of meningococcal infection treated with heparin, dextran 70 and chlorpromazine. Scand J Infect Dis (1972) 0.95
Wernicke's encephalopathy: an experimental study in the rhesus monkey. Acta Neuropathol (1975) 0.94
Effects of somatostatin on hepatic bile formation. Gastroenterology (1989) 0.94
Nonsense mutations of the von Willebrand factor gene in patients with von Willebrand disease type III and type I. Am J Hum Genet (1992) 0.94
An automated turbidimetric immunoassay for plasma proteins. Scand J Clin Lab Invest (1980) 0.94
Chronic polyradiculoneuropathy of infancy. A report of three cases with familial incidence. Neurology (1976) 0.93